Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2011 06:00 ET | Source: MediciNova, Inc.

Reminder: MediciNova to Host Business Update Conference Call by Management on April 7, 2011

SAN DIEGO, April 7, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
April 06, 2011 06:00 ET | Source: MediciNova, Inc.

MediciNova to Host Business Update Conference Call by Management on April 7, 2011

SAN DIEGO, April 6, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
March 31, 2011 17:15 ET | Source: MediciNova, Inc.

MediciNova Reports Fourth Quarter and Full Year 2010 Results

SAN DIEGO, March 31, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka...
March 23, 2011 20:04 ET | Source: MediciNova, Inc.

MediciNova Prices $8.25 Million Public Offering of Common Stock and Warrants

SAN DIEGO, March 23, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange...
March 23, 2011 16:15 ET | Source: MediciNova, Inc.

MediciNova Announces Proposed Public Offering of Common Stock and Warrants

SAN DIEGO, March 23, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange...
March 09, 2011 18:00 ET | Source: MediciNova, Inc.

MediciNova Receives a Notice of Allowance for a Method of Treating Drug Addiction or Dependence

SAN DIEGO, March 9, 2011 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange...
March 03, 2011 16:30 ET | Source: MediciNova, Inc.

Joint Venture Announced

SAN DIEGO, March 3, 2011 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities...
December 13, 2010 16:30 ET | Source: MediciNova, Inc.

Columbia University/New York State Psychiatric Institute and MediciNova Report Preliminary Safety and Efficacy of Ibudilast in Heroin-dependent Volunteers

SAN DIEGO, Dec. 13, 2010 (GLOBE NEWSWIRE) -- Drug addiction investigators with joint appointments at Columbia University Medical Center and the New York State Psychiatric Institute (NYSPI) along with...
November 15, 2010 18:13 ET | Source: MediciNova, Inc.

MediciNova Reports Third Quarter 2010 Results

SAN DIEGO, Nov. 15, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
October 28, 2010 17:00 ET | Source: MediciNova, Inc.

MedicNova Announces Poster Presentations at Annual Meeting of the American College of Chest Physicians

SAN DIEGO, Oct. 28, 2010 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities...